UAB is the first medical center in the Southeast to implant a new type of electrical stimulator to control seizures in patients with epilepsy.
Research in personalized medicine, health informatics and genomic medicine spans disciplines and will impact the treatment of many diseases.
New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.
Anthony Nicholas, M.D., associate professor in the Department of Neurology at the University of Alabama at Birmingham, is a co-editor of the first textbook on the subject of protein deimination in human health and disease.
Published in Faculty Excellence
A new UAB clinic can predict risk for developing Alzheimer’s disease and offer strategies to reduce that risk.
Published in Focus on Patient Care
As part of its ongoing Science, Communication and Innovation talks, Lucas Pozzo-Miller will speak about Rett syndrome.
Published in Service to Community
A new NIH grant could allow researchers to better predict risk factors for patients using blood-thinners by examining the influence of genes, lifestyle, clinical factors and environment.
Parkinson’s disease awareness is highlighted with official recognition from Alabama and the city of Birmingham in April.
Published in Service to Community
The University of Alabama System Board of Trustees approved two endowed positions, an endowed lectureship and three emeritus promotions.
Published in Faculty Excellence
Cash awards were given for best oral and poster presentations at the 9th Annual Health Disparities Research Symposium.
Published in Faculty Excellence
Learn about Lou Gehrig’s disease at the second UAB Neuroscience Café at the Hoover Library.
Published in Faculty Excellence
UAB has teamed with the Michael J. Fox Foundation to look for genetic biomarkers for Parkinson’s disease.
Published in Focus on Patient Care
The University of Alabama System Board of Trustees approve new endowments, promotions and programs during its Feb. 7 meeting.
Published in Faculty Excellence
Neuroscience Café serves healthy portions of fascinating topics in the field of neuroscience at 6:30 p.m. on the third Monday of every month.
Published in Student Experience
Researchers at UAB show that high-intensity strength training improves mobility, mood and overall quality of life for Parkinson’s patients.
Published in Focus on Patient Care
CNET promotes the discovery of novel treatments for neurodegenerative disorders, teaches scientists and clinicians about these diseases, and facilitates the application of these discoveries to the clinical care of patients.
Published in Faculty Excellence
Gel form of a medication for Parkinson’s disease speeds response time over traditional pills.

A national group of leading scientists, including one University of Alabama at Birmingham expert, says fewer people are dying of stroke, but the mechanisms remain unknown.



This group, newly established as an AES committee, is charged with promoting and tracking progress in areas targeted as potential epilepsy benchmarks by NINDS.
Published in Faculty Excellence

The program supports and cultivates students interested in Parkinson’s related research projects.

Published in Student Experience
Page 1 of 3
Back to Top